Bridging Science, Markets & Lives
Asia’s first fully integrated MedTech venture builder. We empower breakthrough healthcare startups with the capital, regulatory insight, and commercialization infrastructure needed to scale successfully across APAC.
Why Syndesia?
- 70% of medtech startups fail to reach Series A.
- Investors face unclear regulatory, market, and commercialization pathways.
- Hospitals and patients wait years for innovations that could save lives.
We change this.
Syndesia orchestrates the end-to-end journey from idea to commercialization, de-risking every stage so that innovation becomes impact.
Syndesia Methodology: The Proof Pathway
Proof of Concept
Does it work?
Proof of Value
Do customers want it?
Proof of Manufacturing
Can it scale?
Proof of Usability
Does it fit clinical workflows?
Proof of Commercialisability
Can it be sold?
Proof of Investability
Will it deliver ROI?
Leverage your workflow
with our services
Get in touch with us to explore development opportunities.
Contact Us